DIGITAL EDITION

ARCHIVES

CURRENT ISSUE

The Pathophysiology of Marijuana-induced Encephalopathy and Possible Epilepsy after Ingestion in Children: A Case Series

by Alister Carvalho, MBBS, and Tracy Evans-Gilbert, DM, MPH, CTropMed® Drs. Carvalho and Evans-Gilbert are with the Department of Pediatrics at the Cornwall Regional Hospital in Montego Bay, Jamaica. Dr.

Panic Attacks in Hyperaldosteronism

by Tiffany Y. Lin, MD; Rebecca M. Hedrick, MD; and Waguih William IsHak, MD, FAPA Drs. Lin and IsHak are with the David Geffen School of Medicine at University of

Therapeutic Potential of Ponesimod Alone and in Combination with Dimethyl Fumarate in Experimental Models of Multiple Sclerosis

by Laetitia Pouzol, MSc, PharmD; Luca Piali, PhD; Claude CA Bernard, PhD; Marianne M. Martinic, PhD; Beat Steiner, PhD; and Martine Clozel, MD Drs. Pouzol and Clozel were with Actelion

The Top Three Things to Know about the Top Three Risk Management Issues

by Charles D. Cash, JD, LLM Mr. Cash is Assistant Vice President at PRMS, Inc. in Arlington, Virginia. Funding: No funding was provided for the preparation of this article. Disclosures:

Editorial Message and Issue Highlights–Vol. 16, No. 1–2, January-February 2019

Dear Colleagues: Welcome to the January–February 2019 issue of Innovations in Clinical Neuroscience (ICNS). We start this issue with a review article by Yeo et al titled, “Virtual Reality Neurorehabilitation

Virtual Reality Neurorehabilitation for Mobility in Spinal Cord Injury: A Structured Review

by Elizabeth Yeo, BS; Brian Chau, MD; Bradley Chi, BS; David E. Ruckle, BS; and Phillip Ta, MD Ms. Yeo, Dr. Chau, Mr. Chi, and Dr. Ta are with the